masoprocol and betadex
masoprocol has been researched along with betadex in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Glabe, CG; Kayed, R; Milton, S; Necula, M | 1 |
| Blomberg, JA; Goodman, AB; Heller, J; Lopez, RA; Rhodes, M | 1 |
Other Studies
2 other study(ies) available for masoprocol and betadex
| Article | Year |
|---|---|
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Humans; Plaque, Amyloid; Protein Structure, Quaternary; Thermodynamics | 2007 |
The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Dimethyl Sulfoxide; Excipients; Female; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Masoprocol; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Polyethylene Glycols; Survival Analysis | 2007 |